🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Recruitingn/aAges 18 Years - anyAllCentury Therapeutics, Inc.
NCT05768269 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is an observational study, and the elements of the study design allow for important follow-up for safety, survival, and the continued evaluation of any late adverse events (AEs) that may appear after treatment with such cellular products. Additionally, collection of persistence data from participants will support the identification of any long-term risks or late AEs that may be causally related to treatment with such cellular products.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Participant has provided written informed consent prior to any long-term follow-up (LTFU) study-specific procedures. * Participants received at least one treatment with a cellular therapy product in an eligible index trial. * Participant was withdrawn, early discontinued or completed an eligible index trial. * Participant is willing and able to comply with scheduled visits, study plan, and other study procedures. Exclusion Criteria: -This study has no exclusion criteria.
💊

What it tests

  • No Intervention
📍

Where

7 sites
Banner MD Anderson Cancer Center
Gilbert, United States
University of Southern California - Norris Comprehensive Cancer Center
Los Angeles, United States
University of Maryland Medical Center
Baltimore, United States
Corewell Health
Grand Rapids, United States
Levine Cancer Institute
Charlotte, United States
University of Cincinnati Medical Center
Cincinnati, United States
Swedish Cancer Institute
Seattle, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy